A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

Part of paid clinical trials in Mobile, Alabama.

Sponsor
Bristol-Myers Squibb
Study ID
NCT03143153
Phase
PHASE3
Status
Completed

Conditions

  • Various Advanced Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Nivolumab — BIOLOGICAL
    Specified dose on specified days
  • Ipilimumab — BIOLOGICAL
    Specified dose on specified days
  • Cisplatin — DRUG
    Specified dose on specified days
  • Fluorouracil — DRUG
    Specified dose on specified days

Study Details

The main purpose of this study is to compare how long subjects with esophageal cancer live overall or live without disease progression after receiving nivolumab and ipilimumab or nivolumab combined with fluorouracil plus cisplatin versus fluorouracil plus cisplatin

Key Dates

Start date
Jun 29, 2017
Status verified
Feb 2026
Primary completion
Jan 18, 2021
Completion
Jan 13, 2025

Study Design

Enrollment
970 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Nivolumab + Ipilimumab
  • Experimental: Nivolumab + Cisplatin + Fluorouacil
  • Active Comparator: Cisplatin + Fluorouracil

Primary Outcome Measure

Overall Survival (OS) in Participants With Tumor Cell PD-L1 [ Time Frame: From the date of randomization to up to the date of death (up to approximately 20 months) ]

Locations (16)

FacilityCityStateZIPSite coordinators
Local Institution - 0191MobileAlabama36608-
Arizona Cancer CenterTucsonArizona85724-
Usc/Norris Comprehensive Cancer CenterLos AngelesCalifornia90033-
Local Institution - 0188DenverColorado80218-
Local Institution - 0186MiamiFlorida33176-
University Of Miami Sylvester Comprehensive Cancer CenterMiamiFlorida33136-
Local Institution - 0225TampaFlorida33612-
Local Institution - 0074AtlantaGeorgia30322-
Local Institution - 0032MariettaGeorgia30060-
Hackensack Meridian Jersey Shore University Medical CenterNeptune CityNew Jersey07753-
Oncology Associates Of Oregon, PcEugeneOregon97401-
Northwest Cancer Specialists, P.C.PortlandOregon97227-
Local Institution - 0210DallasTexas75246-
Local Institution - 0028HoustonTexas77030-
Local Institution - 0190RoanokeVirginia24014-
Local Institution - 0203MorgantownWest Virginia26506-9162-

Find similar trials in Mobile, AL